University of California San Francisco
Give to UCSF
Family therapy for 12- to 18-year-olds with anorexia nervosa, in which all household members participate and a meal is held in the clinician’s office, may be less effective than a streamlined model involving only the parents and without the meal.
Researchers have identified a pair of tarantula toxins that target a previously unknown pain pathway in sensory nerves.
For his pioneering research on plasticity, the brain’s remarkable capacity to modify its structure and function, UCSF's Michael M. Merzenich, PhD, has been awarded the 2016 Kavli Prize in Neuroscience.
A team of researchers led by UCSF scientists has demonstrated in mice that it is possible to generate healthy new liver cells within the organ itself, making engraftment unnecessary.
Researchers at UC San Francisco and Stanford University have performed the first comprehensive survey of the central genes and proteins essential to bacterial life.
Children aged 6 and under with intermittent wheezing triggered by colds may not need to take inhaled steroids on a daily basis to limit the flare-ups that can result in emergency treatment.
Phototherapy, increasingly used to treat jaundiced infants, could very slightly raise the risk of pediatric cancers, particularly myeloid leukemia, according to epidemiological research published, online Monday, May 23, in Pediatrics.
A research team led by UC San Francisco scientists has discovered a cellular signaling system that regulates the virulence of Cryptococcus neoformans, a fungus that has been estimated to cause nearly a million cases of meningitis worldwide per year, about 625,000 of which are fatal.
A national study led by a UCSF oncologist has found that patients with metastatic colon cancer that develops on the left side of the colon survive significantly longer than those with cancer that develops on the right side.
The UCSF Graduate Division has published the first comprehensive study of career outcomes for UCSF’s postdoctoral scholars and possibly the largest single-institution study on the subject conducted to date.
A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.
UC San Francisco researchers have shed light on how the immune system of a fetus can run amok, triggering inflammation in the developing intestines that protrude outside of the body through a hole beside the belly button.
Direct-to-consumer commercial telemedicine sites remotely treating patients for skin disease engaged in practices that put patients’ health and safety at risk.
UCSF has received a four-year, $2.4 million National Institutes of Health grant for an international study on the potential of femoral fractures from osteoporosis drugs.
